SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 58.48 |
Enterprise Value ($M) | -94.67 |
Book Value ($M) | 151.46 |
Book Value / Share | 5.59 |
Price / Book | 0.39 |
NCAV ($M) | 143.25 |
NCAV / Share | 5.29 |
Price / NCAV | 0.41 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.36 |
Return on Assets (ROA) | -0.29 |
Return on Equity (ROE) | -0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 16.92 |
Current Ratio | 16.92 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 169.34 |
Assets | 177.54 |
Liabilities | 26.08 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -68.61 |
Net Income | -61.43 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -47.42 |
Cash from Investing | -2.08 |
Cash from Financing | 135.69 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Ra Capital Management, L.p. | 0.00 | -100.00 | |
13G/A | Point72 Asset Management, L.P. | 8.80 | 39.41 | |
13G/A | Fmr Llc | 4.70 | -46.44 | |
13G | Etkin Amit | 5.40 | ||
13G | BlackRock, Inc. | 5.40 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
85,958 | 245,168 | 35.06 | |
46,934 | 206,189 | 22.76 | |
27,485 | 123,319 | 22.29 | |
50,270 | 201,376 | 24.96 | |
(click for more detail) |
Similar Companies | |
---|---|
ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
ADCT – ADC Therapeutics SA | ANVS – Annovis Bio, Inc. |
BHC – Bausch Health Companies Inc. |
Financial data and stock pages provided by
Fintel.io